Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Oncology Institute (TOI) Other Gross PP&E Adjustments (2020 - 2025)

Oncology Institute (TOI) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$19.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 19.04% year-over-year to -$19.4 million, compared with a TTM value of -$19.4 million through Sep 2025, up 19.04%, and an annual FY2024 reading of -$14.6 million, up 56.21% over the prior year.
  • Other Gross PP&E Adjustments was -$19.4 million for Q3 2025 at Oncology Institute, up from -$23.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$926000.0 in Q4 2021 and bottomed at -$33.4 million in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$21.3 million, with a median of -$22.3 million recorded in 2022.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 2204.1% in 2022, then skyrocketed 56.21% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at -$926000.0 in 2021, then tumbled by 2204.1% to -$21.3 million in 2022, then crashed by 56.61% to -$33.4 million in 2023, then surged by 56.21% to -$14.6 million in 2024, then plummeted by 32.77% to -$19.4 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for TOI at -$19.4 million in Q3 2025, -$23.8 million in Q2 2025, and -$26.3 million in Q1 2025.